VOLUME 23 , ISSUE 11 ( November, 2019 ) > List of Articles
Prateek, Vandana Sharma, Naveen Paliwal, Himani Tak
Keywords : Cerebral infarction, Dengue, Guillain–Barré syndrome, Intravenous immunoglobulin
Citation Information : P, Sharma V, Paliwal N, Tak H. Dengue, Guillain–Barré Syndrome, and Cerebral Infarction: A Case of Rare Complication. Indian J Crit Care Med 2019; 23 (11):533-535.
DOI: 10.5005/jp-journals-10071-23285
License: CC BY-NC 4.0
Published Online: 01-11-2019
Copyright Statement: Copyright © 2019; The Author(s).
Incidence of cerebral infarction after use of intravenous immunoglobulin (IVIG) for treatment of Guillain–Barré syndrome (GBS) is relatively uncommon. Here, we discuss a case of 30-year-old female who was admitted with a complain of thrombocytopenia after infection with dengue virus, who then developed GBS just after a day of discharge. But her woes did not end there, as the GBS progressed rapidly involving her respiratory muscles, leaving her in need of ventilation assistance. Her condition was further deteriorated by development of cerebral infarction that may have been precipitated by the administration of IVIG during the early course of management. Key messages: Intravenous immunoglobulin in a GBS patient with a hematological abnormality (dengue) should be used with caution. Therapeutic plasma exchange may be considered for management in cases with variable coagulability.
© Jaypee Brothers Medical Publishers (P) LTD.
We use cookies on this site to enhance your user experience.
By clicking any link on this page you are giving your consent for us to set cookies.